WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016177660) THE USE OF SGC STIMULATORS, SGC ACTIVATORS, ALONE AND COMBINATIONS WITH PDE5 INHIBITORS FOR THE TREATMENT OF DIGITAL ULCERS (DU) CONCOMITANT TO SYSTEMIC SCLEROSIS (SSC)
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/177660    International Application No.:    PCT/EP2016/059734
Publication Date: 10.11.2016 International Filing Date: 02.05.2016
IPC:
A61K 31/426 (2006.01), A61K 31/427 (2006.01), A61K 31/4439 (2006.01), A61K 31/506 (2006.01), A61K 31/519 (2006.01), A61K 31/5377 (2006.01), A61K 31/635 (2006.01), A61K 45/06 (2006.01), A61P 17/02 (2006.01)
Applicants: BAYER PHARMA AKTIENGESELLSCHAFT [DE/DE]; Müllerstraße 178 13353 Berlin (DE)
Inventors: HIRTH-DIETRICH, Claudia; (DE).
SANDNER, Peter; (DE).
STASCH, Johannes-Peter; (IT).
HAHN, Michael; (DE).
FOLLMANN, Markus; (DE).
VAKALOPOULOS, Alexandros; (DE)
Agent: BIP PATENTS; c/o Bayer Intellectual Property GmbH Alfred-Nobel-Str. 10 40789 Monheim am Rhein (DE)
Priority Data:
15166516.3 06.05.2015 EP
Title (EN) THE USE OF SGC STIMULATORS, SGC ACTIVATORS, ALONE AND COMBINATIONS WITH PDE5 INHIBITORS FOR THE TREATMENT OF DIGITAL ULCERS (DU) CONCOMITANT TO SYSTEMIC SCLEROSIS (SSC)
(FR) UTILISATION DE STIMULATEURS DE LA SGC, D'ACTIVATEURS DE LA SGC, SEULS ET EN COMBINAISONS AVEC DES INHIBITEURS DE PDE5 POUR LE TRAITEMENT D'ULCÈRES DIGITAUX (DU) ASSOCIÉS À LA SCLÉRODERMIE SYSTÉMIQUE (SSC)
Abstract: front page image
(EN)Use of s GC stimulators, sGC activators alone, or in combination with PDE5 inhibitors for the prevention and healing of Digital Ulcers which are concomitant to fibrotic diseases, such as systemic sclerosis and scleroderma.
(FR)La présente invention concerne l'utilisation de stimulateurs de la sGC, d'activateurs de la sGC, seuls, ou en combinaison avec des inhibiteurs de PDE5, pour la prévention et la cicatrisation d'ulcères digitaux associés à des maladies fibrotiques, telles que la sclérodermie et la sclérodermie systémique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)